Research Article

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

Figure 5

Growth inhibition of cabozantinib to renal cancer 786-O and ACHN cells. 786-O and ACHN cells were treated with 2.5 μg/ml cabozantinib or vehicle (DMSO) for 1, 2, 3, and 4 days then assayed for growth and viability by CCK-8 assay. ; ; .